저침습 흉부외과 수술 시장 성장, 규모, 동향 분석 - 유형별 예측, 지역적 전망 및 경쟁 전략(-2034년)

Minimally Invasive Thoracic Surgery Market Introduction and Overview

According to SPER market research, 'Global Minimally Invasive Thoracic Surgery Market Size- By Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Minimally Invasive Thoracic Surgery Market is predicted to reach 8.07 billion by 2034 with a CAGR of 6.06%.

Minimally invasive thoracic surgery allows surgery in the chest through small cuts instead of large openings, without needing to spread the ribs. Surgeons use a camera and tools to access the lung through small openings between the ribs. There are two main types of this surgery: video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery. In VATS, a thoracoscope, which is a small tube with a camera, is placed through an incision between the ribs, enabling the surgeon to see the chest cavity without fully opening it.

Restraints: Implementing minimally invasive techniques requires significant upfront investments in advanced surgical technologies, like robotic systems and special tools. These technologies demand high capital costs, maintenance, and ongoing training for staff. Consequently, many healthcare facilities, especially in developing areas, may find it hard to make these investments, which limits the use of minimally invasive techniques.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Type.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Medtronic, Dextera Surgical Inc, Intuitive surgical Operations, Inc, Richard Wolf GmBH Grena Ltd, Medela, LivaNova PLC, Teleflex Incorporated, Sklar Surgical Instruments

Minimally Invasive Thoracic Surgery Market Segmentation:

By Type: Based on the Type, Global Minimally Invasive Thoracic Surgery Market is segmented as; Lobectomy, Wedge Resection, Pneumonectomy, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPERs internal database
  • 2.1.4. Premium insight from KOLs
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTERs Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Minimally Invasive Thoracic Surgery Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Minimally Invasive Thoracic Surgery Market

7. Global Minimally Invasive Thoracic Surgery Market, By Type (USD Million) 2021-2034

• 7.1. Lobectomy
• 7.2. Wedge Resection
• 7.3. Pneumonectomy
• 7.4. Others

8. Global Minimally Invasive Thoracic Surgery Market, (USD Million) 2021-2034

• 8.1. Global Minimally Invasive Thoracic Surgery Market Size and Market Share

9. Global Minimally Invasive Thoracic Surgery Market, By Region, (USD Million) 2021-2034

• 9.1. Asia-Pacific
  • 9.1.1. Australia
  • 9.1.2. China
  • 9.1.3. India
  • 9.1.4. Japan
  • 9.1.5. South Korea
  • 9.1.6. Rest of Asia-Pacific
• 9.2. Europe
  • 9.2.1. France
  • 9.2.2. Germany
  • 9.2.3. Italy
  • 9.2.4. Spain
  • 9.2.5. United Kingdom
  • 9.2.6. Rest of Europe
• 9.3. Middle East and Africa
  • 9.3.1. Kingdom of Saudi Arabia
  • 9.3.2. United Arab Emirates
  • 9.3.3. Qatar
  • 9.3.4. South Africa
  • 9.3.5. Egypt
  • 9.3.6. Morocco
  • 9.3.7. Nigeria
  • 9.3.8. Rest of Middle-East and Africa
• 9.4. North America
  • 9.4.1. Canada
  • 9.4.2. Mexico
  • 9.4.3. United States
• 9.5. Latin America
  • 9.5.1. Argentina
  • 9.5.2. Brazil
  • 9.5.3. Rest of Latin America

10. Company Profile

• 10.1. Medtronic
  • 10.1.1. Company details
  • 10.1.2. Financial outlook
  • 10.1.3. Product summary
  • 10.1.4. Recent developments
• 10.2. Dextera Surgical Inc
  • 10.2.1. Company details
  • 10.2.2. Financial outlook
  • 10.2.3. Product summary
  • 10.2.4. Recent developments
• 10.3. Intuitive surgical Operations, Inc
  • 10.3.1. Company details
  • 10.3.2. Financial outlook
  • 10.3.3. Product summary
  • 10.3.4. Recent developments
• 10.4. Richard Wolf GmBH
  • 10.4.1. Company details
  • 10.4.2. Financial outlook
  • 10.4.3. Product summary
  • 10.4.4. Recent developments
• 10.5. Grena Ltd
  • 10.5.1. Company details
  • 10.5.2. Financial outlook
  • 10.5.3. Product summary
  • 10.5.4. Recent developments
• 10.6. Medela
  • 10.6.1. Company details
  • 10.6.2. Financial outlook
  • 10.6.3. Product summary
  • 10.6.4. Recent developments
• 10.7. LivaNova PLC
  • 10.7.1. Company details
  • 10.7.2. Financial outlook
  • 10.7.3. Product summary
  • 10.7.4. Recent developments
• 10.8. Teleflex Incorporated
  • 10.8.1. Company details
  • 10.8.2. Financial outlook
  • 10.8.3. Product summary
  • 10.8.4. Recent developments
• 10.9. Sklar Surgical Instruments
  • 10.9.1. Company details
  • 10.9.2. Financial outlook
  • 10.9.3. Product summary
  • 10.9.4. Recent developments
• 10.10. Others

11. Conclusion

12. List of Abbreviations

13. Reference Links